Investing T1 Settlement Funds

Credit from T1 holdings unavailable on the same day on Kite

From WebNotes, a public knowledge base. Last updated . Reading time ~3 min.

When you sell a T1 holding (shares bought today, not yet settled) on Kite , the cash proceeds become available based on the SEBI T+1 settlement cycle, not immediately. This article explains why and how to work with it.

What T1 means

After SEBI’s T+1 settlement transition completed in January 2023, Indian equity trades settle one trading day after execution:

  • Trade day (T): You buy shares.
  • T+1: Shares are credited to your demat; cash debited.

Until T+1 settlement completes, the shares are flagged as T1 on the Kite Holdings tab (or in the position queue, depending on Kite build). They can be sold via the BTST flow, but the sale proceeds are subject to the same settlement cycle.

The proceeds timeline

For a BTST sale of T1 holdings:

TimeEvent
Day TBuy shares CNC; sell same day (BTST)
Day T eveningTrade book records both the buy and the sell
Day T+1Buy settles (shares credit); sell settles (shares debit); net effect: zero shares
Day T+1 eveningProceeds reflect in the trading account
Day T+2 morningProceeds usable for new buys

This is the T+1 settlement cycle applied to both legs. The proceeds are unavailable on day T (the trade day) for new buy orders.

Why the proceeds are not immediate

Settlement happens at the clearing corporation level. NSE Clearing (NSCCL) batches trades end-of-day on T, computes net obligations, and processes the netted positions for delivery on T+1. Until that batch runs, the cash from your sell is not in your account; it is in the clearing corporation’s pipeline.

This applies to all retail equity trades, not just BTST. The reason it is more visible for BTST is that the sale happens on day T, when the buy is still settling.

Buying more on day T

If you sold T1 shares for Rs 5 lakh on day T, can you buy Rs 5 lakh more on day T? Yes, but using:

  • Existing free funds (already in your trading account from prior days).
  • Margin (if F&O / pledge available).

Not using:

  • The Rs 5 lakh from today’s sell: those proceeds are not yet in your account.

CNC vs MIS for fresh buys on day T

ProductFunds source allowed on day T
CNC (delivery)Existing free funds; pledged collateral cannot fund equity delivery purchases
MIS (intraday)Existing free funds + intraday leverage
F&OExisting free funds + pledged collateral + cash component

The T1 proceeds are not yet usable for any of these on day T.

Workaround: planning around T+1

For active investors:

  • Maintain a buffer in the trading account for new opportunities.
  • Use intraday MIS if you must trade with T1-equivalent proceeds (caveat: MIS auto-squares end of day).
  • Avoid BTST cycles that depend on quick redeployment of proceeds.

Same constraint applies to direct CNC sell

If you sell a settled CNC holding (not T1) on day T, the proceeds are still T+1. You can use them for new CNC buys on T+1 morning.

The “T1 unavailable” message specifically refers to: shares whose buy is still settling cannot have their sale proceeds used on day T.

See also

External references

References

  1. SEBI, T+1 settlement cycle implementation, circular dated 7 September 2021 and subsequent.
  2. NSE Clearing, Settlement schedule for equity, nseclearing.com.
  3. Zerodha Support, T1 holdings and same-day proceeds, support.zerodha.com.

Reviewed and published by

The WebNotes Editorial Team covers Indian capital markets, payments infrastructure and retail investor procedures. Every article is fact-checked against primary sources, principally SEBI circulars and master directions, NPCI specifications and the official support documentation published by the intermediary in question. Drafts go through a second-pair-of-eyes review and a separate compliance read before publication, and revisions are tracked against the SEBI and NPCI rule changes referenced in the methodology section.

Last reviewed
Conflicts of interest
WebNotes is independent. No relationship with any broker, registrar or bank named in this article.